ISPOR Europe 2025
9 - 12 November
-
Identifying Factors Associated With Involvement in Healthcare Decisions in Wales
Sep 9, 2025, 16:22 PM -
Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals
Sep 9, 2025, 16:22 PM -
Accounting for the Additional Uncertainty Following Rank-Preserving Structural Failure Time Model (RPSFTM) Crossover Adjustment in Survival Analysis: A Sage Approach
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Incidence and Treatment of Squamous-Cell Anal Cancer (SCAC) in Germany: A Retrospective Study in German Statutory Health Insurance (SHI) Claims Data
Sep 9, 2025, 16:22 PM -
The Acceptability of Wearables in Remote Monitoring According to Health Technology Assessment HTA Bodies
Sep 9, 2025, 16:22 PM -
Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective
Sep 9, 2025, 16:22 PM -
Integrating Stakeholder Willingness-to-Pay Using the Van Westendorp Price Sensitivity Meter Into Cost-Effectiveness Analysis: A Mixed-Methods Pricing Framework
Sep 9, 2025, 16:22 PM -
Navigating Implementation of the EU HTA Regulation for Medical Devices: Insights From National HTA Bodies Across Europe
Sep 9, 2025, 16:22 PM -
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Sep 9, 2025, 16:22 PM -
Socioeconomic Burden Among Children and Adults With Achondroplasia in Europe and Latin America
Sep 9, 2025, 16:22 PM -
Effect of Positive Airway Pressure Therapy on Mortality in European Obstructive Sleep Apnea Patients: Post Hoc Analysis of a Global Meta-Analysis
Sep 9, 2025, 16:22 PM -
Evaluating Cost Benefits of Subcutaneous vs. Intravenous Trastuzumab/Pertuzumab in HER2-Positive Early Breast Cancer Patients: From Qatari Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Urinary Dysfunction Management in Multiple Sclerosis: A Nationwide Real-Life Analysis From the French SNDS Database
Sep 9, 2025, 16:22 PM -
Economic Burden of COVID-19-Related Hospitalizations in Finland: A 4-year Longitudinal Analysis
Sep 9, 2025, 16:22 PM -
The Health Economic Case for AI in Radiology: A Systematic Review and Appraisal of Evaluation Quality and Methods
Sep 9, 2025, 16:22 PM -
AI Powered SQL for Real-World Data: From Questions to Insights
Sep 9, 2025, 16:22 PM -
Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study
Sep 9, 2025, 16:22 PM -
Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies
Sep 9, 2025, 16:22 PM -
A Data-Driven Framework for Rare Disease Protocol Design: Integrating Real-World Evidence, Patient Perspectives, and Regulatory Guidance
Sep 9, 2025, 16:22 PM